iRadimed
IRMD
54 hedge funds and large institutions have $107M invested in iRadimed in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 9 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 18
11% more capital invested
Capital invested by funds: $96.8M → $107M (+$10.3M)
1.43% more ownership
Funds ownership: 36.88% → 38.3% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 62 → 54 (-8)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$2.65M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.43M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$910K |
| 4 |
Morgan Stanley
New York
|
+$894K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$652K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$852K |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$831K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$622K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$488K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$473K |
IRMD Hedge Fund Activity: Q4 2020 in Review
54 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2020, worth a combined $107M — up 11% from $96.8M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of IRMD and 2 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 24 added.
The largest buyer was Nine Ten Capital Management, adding an estimated $2.65M. The largest seller was Ranger Investment Management, cutting an estimated $852K.
- 54 institutional investors held iRadimed (IRMD) as of Q4 2020, down from 62 in Q3 2020.
- Funds reported $107M of iRadimed stock for Q4 2020, up 11% quarter-over-quarter.
- 2 funds opened new iRadimed positions in Q4 2020 and 9 closed out, a net change of -7 holders.
- The largest iRadimed buyer in Q4 2020 was Nine Ten Capital Management, an estimated $2.65M added.
- The largest iRadimed seller in Q4 2020 was Ranger Investment Management, an estimated $852K sold.
Based on aggregated 13F filings for Q4 2020.